Human African trypanosomiasis in Angola: Clinical observations, treatment, and use of PCR for stage determination of early stage of the disease

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 106, Issue 1, 2012, Pages 10-14

  Truc, P ^a   Lando, A ^b   Penchenier, L ^a   Vatunga, G ^b   Josenando, T ^b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Instituto de Combate e Controlo das Tripanossomiases   (Angola)

Author keywords

Angola; Clinical signs; Human African trypanosomiasis; Stage determination

Indexed keywords

EFLORNITHINE; PENTAMIDINE;

ADULT; AFRICAN TRYPANOSOMIASIS; ANGOLA; ARTICLE; CEREBROSPINAL FLUID; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; TREATMENT FAILURE;

ADULT; ANGOLA; ANIMALS; EFLORNITHINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOCYTE COUNT; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PENTAMIDINE; POLYMERASE CHAIN REACTION; RECURRENCE; REMISSION INDUCTION; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI GAMBIENSE; TRYPANOSOMIASIS, AFRICAN;

EID: 83155181370     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1016/j.trstmh.2011.10.002     Document Type: Article

References (25)

1. Simarro P.P., Jannin J., Cattand P. Eliminating human African trypanosomiasis: where do we stand and what comes next. PloS Med 2008, 5:e55.
2. Stanghellini A., Josenando T. The situation of sleeping sickness in Angola: a calamity. Trop Med Int Health 2001, 6:330-334.
3. Simarro P.P., Giuliano Cecchi G., Paone M., Franco J.R., Diarra A., Ruiz J.A., et al. The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases. Int J Health Geograph 2010, 9:57.
4. Truc P., Mathieu Daudé F., Tibayrenc M. Multilocus isoenzyme identification of Trypanosoma brucei stocks isolated in Central Africa: evidence for an animal reservoir of sleeping sickness in Congo. Acta Trop 1991, 49:127-135.
5. Njiokou F., Laveissière C., Simo G., Nkinin S., Grébaut P., Cuny G., et al. Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon. Infect Genet Evol 2006, 6:147-153.
6. Checchi F., Filipe A.J., Haydon D., Chandramohan D., Chappuis F. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis 2008, 8:8-16.
7. Doua F., Miezan T.W., Sanon Singaro J.R., Boa Yapo F., Baltz T. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg 1996, 55:586-588.
8. Truc P., Jamonneau V., Cuny, Frézil J.L. Polymerase chain reaction for human African trypanosomiasis stage determination and follow-up. Bull World Health Organ 1999, 77:745-748.
9. Deborggraeve S, Lejon V, Ekangu RA, Mumba Ngoyi D, Pati Pyana P, et al. Diagnostic accuracy of PCR in gambiense sleeping sickness, diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study. PloS Negl Trop Dis 2011;5:e972. doi:10.1371/journal.pntd.0000972.
10. WHO. Control and surveillance of African trypanosomiasis. WHO Technical Series 881. Geneva: World Health Organization; 1998.
11. Magnus E., Vervoot T., Van Merveinne N. A card-agglutination test with stained trypanosomes (CATT) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann Soc Belge Méd Trop 1978, 58:169-176.
12. Woo P.T.K. The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis. Acta Trop 1970, 27:384-386.
13. Lumsden W.H.R., Kimber C.D., Evans D.A., Doig S.J. Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitemias; adaptation for field use. Trans R Soc Trop Med Hyg 1979, 73:312-317.
14. Miézan T.W., Meda H.A., Doua F., Djè N.N., Lejon V., Büscher P. Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 2000, 94:293.
15. Mumba Ngoyi D., Lejon V., Pyana P., Boelaert M., Ilunga M., Menten J., et al. How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Inf Dis 2010, 201:453-463.
16. Khonde N., Pépin J., Mpia B. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness. Trans R Soc Trop Med Hyg 1997, 91:212-213.
17. Biteau N., Bringaud F., Gibson W.C., Truc P., Baltz T. Characterization of Trypanozoon isolates using genetic micro- and minisatellite markers. Mol Biochem Parasitol 2000, 105:185-201.
18. Lutje V, Seixas J, Kennedy A. Chemotherapy for second-stage human African trypanosomiasis. Cochrane Database Syst Rev 2010; 8:CD006201. doi:10.1002/14651858.CD006201.pub2.
19. Truc P., Grébaut P., Lando A., Makiadi Donzoau F., Penchenier L., Herder S., et al. Epidemiological aspects of the transmission of human African trypanosomiasis in Angola. Ann Trop Med Parasitol 2011, 105:261-265.
20. Blum J., Schmid C., Burri C. Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 2006, 97:55-64.
21. Deborggrave S., Büscher P. Molecular diagnostics for sleeping sickness: what is the benefit for the patient. Lancet Infect Dis 2010, 10:433-439.
22. Brun R., Blum J., Chappuis F., Burri C. Human African trypanosomiasis. Lancet 2010, 375:148-159.
23. Balasegaram M., Young H., Chappuis F., Priotto G., Raguenaud M.E., Checchi F. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg 2009, 103:280-290.
24. Milord F., Pépin J., Loko L., Ethier, Mpia B. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet 1992, 340:652-655.
25. Priotto G., Kasparian S., Mutumbo W., Ngouama D., Ghorashian S., Arnold U., et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet 2009, 374:56-64.